Cargando…
Case series, chemotherapy-induced cardiomyopathy: mind the family history!
BACKGROUND: Cardiotoxicity presenting as cardiomyopathy is a common side effect in cancer treatment especially with anthracyclines. The role of genetic predisposition is still being investigated. CASE SUMMARY: Four unrelated patients with a familial burden for cardiac disease, who developed cardiomy...
Autores principales: | Moghadasi, Setareh, Fijn, Rienke, Beeres, Saskia L M A, Bikker, Hennie, Jongbloed, Jan D H, Josephus Jitta, Djike, Kroep, Judith R, Lekanne Deprez, Ronald H, Vos, Yvonne J, de Vreede, Mariëlle J M, Antoni, M Louisa, Barge-Schaapveld, Daniela Q C M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536866/ https://www.ncbi.nlm.nih.gov/pubmed/34703979 http://dx.doi.org/10.1093/ehjcr/ytab333 |
Ejemplares similares
-
Large next-generation sequencing gene panels in genetic heart disease: challenges in clinical practice
por: Christiaans, I., et al.
Publicado: (2019) -
Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance
por: van Lint, F. H. M., et al.
Publicado: (2019) -
Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma
por: Heemelaar, Julius C., et al.
Publicado: (2022) -
Genetic variant in the BRAF gene compatible with Noonan spectrum disorders in an adult Fontan patient with refractory protein losing enteropathy: a follow-up report
por: Nederend, Marieke, et al.
Publicado: (2023) -
A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects
por: van der Linde, I. H. M., et al.
Publicado: (2017)